SALT LAKE CITY -- Utah pharmacists will start putting red stickers onthat warn patients about the risk of as part of a new awareness campaign to combat painkiller abuses and deaths.
The Utah Department of Health's monthlong campaign kicks off Monday and is meant to encourage dialogue between pharmacists and patients about opioid risks.
The rate of prescription opioids dispensed in Utah grew 30 percent from 2002 to 2015, statistics from the department show. Nearly 300 Utah residents died of opioid overdoses in 2015, according to the latest data available from the department.
"Given the high number of deaths associated with prescription opioids, understanding the risks of opioids is vital to patient safety," said Angela Dunn, deputy state epidemiologist for the health department.
The new initiative is a collaborative effort by the health department, the Utah Pharmacy Association and the Utah Department of Commerce.
The red stickers -- which read "Caution: Opioid. Risk of Overdose and Addiction" -- will prompt patients to ask pharmacists questions about their potentially addictive medications, said Greg Jones, chairman of the Utah Pharmacy Licensing Board.
"People underestimate the danger of their medications," Jones said. "People think they'll be fine taking it, and quite often they're not."
"We hope that when people see these warning stickers, they will ask us about the medications they have been prescribed and what they should watch for and do in case of a potential overdose," Jones said, according to CBS Salt Lake City affiliate KUTV.
Pharmacists can discuss with patients proper use, storage and disposal of opioids and provide naloxone, an overdose-reversing drug.
KUTV reports that Utah pharmacists may also prescribe naloxone, a medication that can reverse an opioid overdose, without a prior prescription to anyone at increased risk of experiencing an opioid overdose.
The red-sticker campaign is just one of several initiatives the Utah Department of Health has been working on in recent years to reduce opioid overdoses and increase public awareness about the issue.
"It will take some time to see results," Dunn said. "But anecdotally, patients are becoming more educated on what an opioid is and the dangers it can possess."